✦ LIBER ✦

6081 Bevacizumab (BV) in combination with FOLFOXIRI (irinotecan, oxaliplatin and infusional 5FU/LV) in metastatic colorectal cancer (MCRC): updated results of a phase II G.O.N.O. trial

✍ Scribed by Masi, G.; Salvatore, L.; Fornaro, L.; Vasile, E.; Baldi, G.G.; Stasi, I.; Ciarlo, A.; Tuzi, A.; Andreuccetti, M.; Falcone, A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

599 ORAL Improved activity with irinotec

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 262 KB

6096 POSTER FOLFOXIRI (Irinotecan, Oxali

✍ Fornaro, L.; Loupakis, F.; Lonardi, S.; Masi, G.; Salvatore, L.; Cremolini, C.; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 49 KB

6085 FOLFOXIRI (irinotecan, oxaliplatin,

✍ Falcone, A.; Masi, G.; Vasile, E.; Loupakis, F.; Cupini, S.; Mancini, M.; Granet 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

6060 KRAS and BRAF mutational analyses i

✍ Salvatore, L.; Loupakis, F.; Fontanini, G.; Cremolini, C.; Stasi, I.; Fabbri, A. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

A randomized phase II trial assessing ir

✍ C. Pozzo; S. Pyrhönen; I. Bodrogi; J. Szanto; H. Kamica-Mlodkowska; H. Starkamma 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 119 KB

667 PUBLICATION Capecitabine and oxalipl

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 126 KB